San Luis Obispo Personal Injury Lawyer - FDA & Prescription Drugs

Stolen Insulin Still A Concern Warns The FDA

Chrissie Cole — Wed, 26 Aug 2009 14:08:00 GMT

The FDA is reminding the public that stolen vials of Levimir insulin, made by Novodisk Inc. may still be on the market.

The FDA initially warned the public about 129,000 stolen vials of Levemir that were stolen in North Carolina. To this date, two percent has been recovered so far.

It appears the stolen insulin was not stored or properly handled and may be dangerous for use. Multiple reports of adverse events have been reported to the agency due to poor control of glucose levels after using a vial from one of the stolen lots.

The following lots of Levimir are included in the recall: XZF0036; XZF0037; XZF0038. The lot number is located on the side of the box of insulin and also on the side of the vial.

The agency is aggressively investigating the matter and asks if you have any information to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site.

Originally posted at InjuryBoard by Chrissie Cole

Continued Concerns Regarding Bisphenol A

Nigel Whitehead — Thu, 04 Sep 2008 15:22:49 GMT

The FDA has said that plastic products containing the chemical Bisphenol A are safe. Experts, however, aren't so sure and have reported that they can't completely rule out the dangers of this chemical. Bisphenol A is used in a host of plastic products, including food packaging and baby bottles. Walmart and other retailers have even indicated that they will pull from their shelves all baby products containing the chemical.

Such discrepancies between the FDA and other Federal health experts highlights the trouble of repeated attempts by the "Tort Reform" crowd to ban litigation involving drugs or products approved by the FDA. If Bisphenol A really does cause brain damage in children and manufacturers are aware of the problem, should they really be able to avoid liability because the FDA, for some reason, approved the product. Surely, at some point safety and accountability must trump corporate profits.

Originally posted at InjuryBoard by Nigel Whitehead

Actavis Totowa Recalls Digitek (digoxin) tablets

Susan Devine — Wed, 14 May 2008 18:05:30 GMT

On April 25, 2008 Actavis Totowa LLC, a manufacturer of generic medication, issued a Class I nationwide recall of Digitek, a generic form of digoxin tablets. The company's press release can be found here. The products are distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories under a "UDL" label. The FDA is aware of the recall.

Digitek is used to treat heart failure and abnormal heart rhythms and the voluntary recall was issued because at least some of the tablets that were released were oversized and could contain at least twice the level of active ingredients than is appropriate.

It has been reported that some individuals have been seriously injured as a result of taking the wrong sized tablets. Consumer attorneys are working on lawsuits in the hopes that those who have been injured will be compensated and to help ensure these kinds of mistakes do not happen again. If you have been injured as a result of taking this medication, or even if you are not sure, contact your doctor immediately. And if you have questions about your legal rights, contact a local attorney.

Originally posted at InjuryBoard by Susan Devine